SCHEMBL4616640

SCHEMBL4616640

Cc1cc(COc2ccccc2O)ccc1Br

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.54
GAA P10253 4/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 2/20 0.47
MAOB P27338 2/20 0.46
MAPT P10636 3/20 0.43
LMNA P02545 2/20 0.43
JAK2 O60674 1/20 0.43
FFAR4 Q5NUL3 4/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.42
RXRA P19793 2/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
MAPK1 P28482 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 1/20 0.40
STAT3 P40763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3920520 0.84 GAA (0.54) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL3918660 0.82 APP (0.51) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL3929009 0.82 APP (0.54) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL3918943 0.82 APP (0.54) APPGAASMN1; SMN2ALDH1A1MAOB
Benzyl Bromide SCHEMBL5708224 0.77 GAA (0.47) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL4616641 0.76 APP (0.50) APPGAASMN1; SMN2MAOBMAPT
Benzyl Bromide SCHEMBL5708213 0.75 APP (0.47) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL8960607 0.75 APP (0.76) APPGAASMN1; SMN2ALDH1A1MAOB
SCHEMBL10854605 0.74 APP (0.60) APPGAASMN1; SMN2ALDH1A1MAPT
SCHEMBL27714656 0.74 MAPT (0.49) APPMAOBMAPTLMNAFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1697304-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2008-02-20 EP disclosed
US-20070082907-A1 Peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (IN) 2007-04-12 US disclosed
EP-1697304-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2006-09-06 EP disclosed
WO-2005054176-A1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-06-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070082907-A1 Peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD APP 2636/4885GAA 828/4885SMN1; SMN2 4281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.